CTSK

Cathepsin K · P43235 · CTSK on Sugi Atlas →

324,228 patent compounds predicted against CTSK, 146,094 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL150073 SCHEMBL150073 0.51 18/20
SCHEMBL18535 SCHEMBL18535 0.60 16/20
SCHEMBL56438 SCHEMBL56438 0.50 15/20
SCHEMBL73696 SCHEMBL73696 0.53 14/20
SCHEMBL73697 SCHEMBL73697 0.53 14/20
SCHEMBL75827 SCHEMBL75827 0.53 14/20
SCHEMBL86153 SCHEMBL86153 0.56 13/20
SCHEMBL86185 SCHEMBL86185 0.56 13/20
SCHEMBL165350 SCHEMBL165350 0.47 13/20
SCHEMBL165351 SCHEMBL165351 0.47 13/20
Water Water (SCHEMBL44988) 0.56 12/20
SCHEMBL160926 SCHEMBL160926 0.55 12/20
SCHEMBL84426 SCHEMBL84426 0.53 12/20
SCHEMBL17393 SCHEMBL17393 0.51 12/20
SCHEMBL86237 SCHEMBL86237 0.44 12/20
SCHEMBL86310 SCHEMBL86310 0.44 12/20
SCHEMBL166957 SCHEMBL166957 0.42 12/20
SCHEMBL67061 SCHEMBL67061 0.66 11/20
SCHEMBL10652 SCHEMBL10652 0.53 11/20
SCHEMBL142265 SCHEMBL142265 0.52 11/20

Clinical trials — most relevant to CTSK by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
The Impact of Pcsk-9 Inhibition on PET CFR in Patients at High CV Risk PHASE4RECRUITING
Ulinastatin in Severe Acute Pancreatitis PHASE4SUSPENDED
Efficacy and Safety of Favipiravir and Ribavirin Formulation for Treatment of COVID-19 PHASE2/PHASE3UNKNOWN
STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19 PHASE3COMPLETED
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients PHASE3RECRUITING
Daptomycin Pharmacokinetics in Continuous Veno-venous Hemodiafiltration PHASE2UNKNOWN
The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism EARLY_PHASE1UNKNOWN
Evaluation of the Changes in Matrix Metalloproteinase-9 Levels With Salvadora Persica (Miswak) in Periodontal Fibroblasts and Gingival Crevicular Fluid in Patients With Periodontitis EARLY_PHASE1NOT_YET_RECRUITING
Detection of Cancer-Specific Active Proteases in Blood Via Fluorescence nanWITHDRAWN
Respiratory Cathepsins, Proteases Inhibitors and Glycosaminoglycans (GAG) in Mucopolysaccharidosis nanCOMPLETED
Long Term Outcome of Congenital Solitary Kidney nanUNKNOWN
Synovial Fluid Bank From Arthritic Patients nanRECRUITING
The Benefit of Оn-Line High Convection Volume Hemodiafiltration Treatment Versus High Flow Dialysis on Reduction of Oxidative Stress and Health Related Quality of Life in Dialysis Patients nanCOMPLETED
Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD nanNOT_YET_RECRUITING
Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy Patients nanRECRUITING
Fasting, Exercise, and Diet to Activate Autophagy in Depression nanNOT_YET_RECRUITING
Salivary Biomarkers for Sjögren's Syndrome Detection nanCOMPLETED
Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer nanUNKNOWN
Predicting Pancreatic Necrosis Using mitDNA nanUNKNOWN
The Role of Vitamin K2 in Preventing Glucocorticoid-Induced Bone Loss in Children With Nephrotic Syndrome nanRECRUITING
Comparison of Clinical Efficacy of Submucosal Dexamethasone and Oral Trypsin-chymotrypsin for Reduction of Postoperative Sequelae After Lower Third Molar Surgery nanRECRUITING
A Cohort Study of Correlation Between Mast Cells and Prognosis in Patients With Acute Myocardial Infarction nanUNKNOWN
Biomarkers of Acute Kidney Injury Following Cardiac Surgery nanUNKNOWN
Chemokine Mechanisms in Chronic Pelvic Pain nanCOMPLETED
Correlation Between Serum Markers of Unstable Plaque and Virtual Histology of Unstable Plaque Visualized by IVUS nanCOMPLETED
Acute Pancreatitis Targets (APT) Study nanCOMPLETED
Disorders of the Acute Phase Response Following Trauma and Invasive Surgery nanENROLLING_BY_INVITATION
Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B Virus nanCOMPLETED
Magnetic Nanoparticles System in Acute Coronary Syndrome nanCOMPLETED
Proteases in Patients With Prostate Cancer That Has Spread to the Bone nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a CTSK binder may also engage these)

ProteinNameSimilarity
Q5E968 1.000 Q5E968 →
Q3ZKN1 1.000 Q3ZKN1 →
P61276 1.000 P61276 →
Q9GLE3 0.999 Q9GLE3 →
P61277 0.999 P61277 →
P55097 0.998 P55097 →
P43236 0.998 P43236 →
O35186 0.996 O35186 →
P06797 0.995 P06797 →
CTSV Cathepsin L2 0.994 landscape →
CTSS Cathepsin S 0.994 landscape →
Q9JI81 0.992 Q9JI81 →
P25326 0.991 P25326 →
Q80UB0 0.991 Q80UB0 →
O70370 0.990 O70370 →
P25975 0.990 P25975 →
Q91ZF2 0.989 Q91ZF2 →
Q9QZE3 0.989 Q9QZE3 →
O45734 0.989 O45734 →
Q9GKL8 0.989 Q9GKL8 →
Q9JIA9 0.989 Q9JIA9 →
Q5E998 0.989 Q5E998 →
P25773 0.989 P25773 →
Q63088 0.989 Q63088 →
P15242 0.988 P15242 →
CTSH Pro-cathepsin H 0.988 landscape →
P49935 0.988 P49935 →
Q8HY82 0.988 Q8HY82 →
Q9GL24 0.988 Q9GL24 →
Q8HY81 0.987 Q8HY81 →